Subscribe To
CANSF / Willow Biosciences shares take off on biopharma manufacturing collaboration announcement
Content Topics
Willow
Biosciences
Shares
Take
Biopharma
Manufacturing
Collaboration
Announcement
Stock
CANSF
CANSF News
By Proactive Investors
October 3, 2023
Willow Biosciences and Suanfarma partner to develop large volume anti-infective API through precision fermentation
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) told investors it has partnered with Spanish life science company Suanfarma to bring sustainably source more_horizontal
By Proactive Investors
September 12, 2023
Willow Biosciences announces $1.2M debt offering
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) announced a non-brokered private placement offering of convertible debenture units, with the goal of ra more_horizontal
By Proactive Investors
September 6, 2023
Willow Biosciences completes R&D to produce ursodeoxycholic acid
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) said it has successfully completed research and development on its program to produce ursodeoxycholic more_horizontal
By Proactive Investors
August 30, 2023
Willow Biosciences files patent application for process to produce much cheaper corticosteroids
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) told investors it has filed a patent application for a process it has developed to produce corticostero more_horizontal
By Proactive Investors
August 24, 2023
Willow Biosciences appoints advisor to review opportunities as part of commercial focus on BioOxi platform
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) announced it has engaged an advisor to assist it with a review of opportunities to enhance value for it more_horizontal
By Proactive Investors
August 21, 2023
Willow Biosciences shares take off on biopharma manufacturing collaboration announcement
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF)' Canadian-listed shares had added more than 23% in the early afternoon on Monday after it announced th more_horizontal
By Proactive Investors
August 21, 2023
Willow Biosciences announces collaboration with Nasdaq-listed biopharma
Willow Biosciences Inc (TSX:WLLW, OTCQB:CANSF) has announced a collaboration with an unnamed Nasdaq-listed biopharma company to develop new sustainab more_horizontal
By Proactive Investors
August 9, 2023
Willow Biosciences secures contracts valued at $1M during 2Q
Willow Biosciences told investors that during the second quarter, it closed three new contracts that are expected to bring in more than $1 million in more_horizontal